
ESSA Pharma Inc
NASDAQ:EPIX

Net Margin
ESSA Pharma Inc
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Net Margin Across Competitors
Net Margin Comparison
ESSA Pharma Inc Competitors
Country | CA |
Market Cap | 146m USD |
Net Margin | N/A |
Country | US |
Market Cap | 268B USD |
Net Margin |
15%
|
Country | US |
Market Cap | 143B USD |
Net Margin |
30%
|
Country | US |
Market Cap | 93.7B USD |
Net Margin |
20%
|
Country | US |
Market Cap | 90.8B USD |
Net Margin |
36%
|
Country | US |
Market Cap | 89.6B USD |
Net Margin |
35%
|
Country | AU |
Market Cap | 123B AUD |
Net Margin |
16%
|
Country | US |
Market Cap | 39.8B USD |
Net Margin |
-34%
|
Country | US |
Market Cap | 37.4B USD |
Net Margin |
43%
|
Country | US |
Market Cap | 37B USD |
Net Margin |
27%
|
Country | NL |
Market Cap | 26.7B USD |
Net Margin |
-173%
|
Net Margin Distribution
Net Margin Distribution
Biotechnology Industry
Profitability Report
View the profitability report to see the full profitability analysis for ESSA Pharma Inc.
See Also
Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.
Based on ESSA Pharma Inc's most recent financial statements, the company has Net Margin of 0%.